These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers. Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Wincewicz D; Sulkowski S Folia Histochem Cytobiol; 2009 Jan; 47(3):425-30. PubMed ID: 20164027 [TBL] [Abstract][Full Text] [Related]
24. Production and processing of erythropoietin receptor transcripts in brain. Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476 [TBL] [Abstract][Full Text] [Related]
25. Spatial and Cellular Expression Patterns of Erythropoietin-Receptor and Erythropoietin during a 42-Day Post-Lesional Time Course after Graded Thoracic Spinal Cord Impact Lesions in the Rat. Cohrs G; Goerden S; Lucius R; Synowitz M; Mehdorn HM; Held-Feindt J; Knerlich-Lukoschus F J Neurotrauma; 2018 Feb; 35(3):593-607. PubMed ID: 28895456 [TBL] [Abstract][Full Text] [Related]
26. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814 [TBL] [Abstract][Full Text] [Related]
27. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Mohyeldin A; Lu H; Dalgard C; Lai SY; Cohen N; Acs G; Verma A Neoplasia; 2005 May; 7(5):537-43. PubMed ID: 15967106 [TBL] [Abstract][Full Text] [Related]
28. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153 [TBL] [Abstract][Full Text] [Related]
29. No erythropoietin-induced growth is observed in non-small cell lung cancer cells. Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289 [TBL] [Abstract][Full Text] [Related]
30. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer. Baltaziak M; Koda M; Wincewicz A; Sulkowska M; Kanczuga-Koda L; Sulkowski S Anticancer Res; 2009 Oct; 29(10):4151-6. PubMed ID: 19846965 [TBL] [Abstract][Full Text] [Related]
31. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. Boer K; Helinger E; Helinger A; Pocza P; Pos Z; Demeter P; Baranyai Z; Dede K; Darvas Z; Falus A Eur J Cell Biol; 2008 Apr; 87(4):227-36. PubMed ID: 18258331 [TBL] [Abstract][Full Text] [Related]
32. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors. Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826 [TBL] [Abstract][Full Text] [Related]
33. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study. Cardillo MR; Yap E J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902 [TBL] [Abstract][Full Text] [Related]
34. STAT3, HIF-1alpha, EPO and EPOR - signaling proteins in human primary ductal breast cancers. Wincewicz A; Sulkowska M; Koda M; Leśniewicz T; Kanczuga-Koda L; Sulkowski S Folia Histochem Cytobiol; 2007; 45(2):81-6. PubMed ID: 17597020 [TBL] [Abstract][Full Text] [Related]
35. Erythropoietin receptor function and expression in epithelial ovarian carcinoma. McBroom JW; Acs G; Rose GS; Krivak TC; Mohyeldin A; Verma A Gynecol Oncol; 2005 Dec; 99(3):571-7. PubMed ID: 16051335 [TBL] [Abstract][Full Text] [Related]
36. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation. Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950 [TBL] [Abstract][Full Text] [Related]
37. Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality. Westphal G; Niederberger E; Blum C; Wollman Y; Knoch TA; Rebel W; Debus J; Friedrich E Tumori; 2002; 88(2):150-9. PubMed ID: 12088257 [TBL] [Abstract][Full Text] [Related]
38. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer. Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036 [TBL] [Abstract][Full Text] [Related]
39. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro. Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518 [TBL] [Abstract][Full Text] [Related]
40. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. García-Ramírez M; Hernández C; Simó R Diabetes Care; 2008 Jun; 31(6):1189-94. PubMed ID: 18332162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]